Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01880385

Femme Homme

  • | Pays :
  • Tunisia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Multi-center, non randomised, open label, non controlled pilot study. Evaluating the treatment of bevacizumab in association with pre-operative chemotherapy, followed by surgery, adjuvant chemotherapy and radiotherapy in Patients with inflammatory breast cancer.


Critère d'inclusion

  • Inflammatory Breast Cancer

Liens